Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2007 by ProteoSys AG.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborators:
Charite University, Berlin, Germany
University Hospital Tuebingen
Medical Centre, Ludwigshafen, Germany
Medical University Innsbruck
Information provided by:
ProteoSys AG
ClinicalTrials.gov Identifier:
NCT00400894
First received: November 16, 2006
Last updated: February 2, 2007
Last verified: February 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2006
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):